North America Next-generation Sequencing Market worth $11.63 billion by 2030
The report "North America Next-generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Service, Application (Drug Discovery, Diagnostic, Agriculture) - Forecast to 2030", North America next-generation sequencing market is projected to reach USD 11.63 billion by 2030 from USD 6.15 billion in 2025, at a CAGR of 13.6% during the forecast period of 2025 to 2030.
Browse 350 market data Tables and 45 Figures spread through 250 Pages and in-depth TOC on "North America Next-generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Service, Application (Drug Discovery, Diagnostic, Agriculture) - Forecast to 2030 "
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/north-america-next-generation-sequencing-market-86712553.html
Several factors are driving the growth of the North American next-generation sequencing (NGS) market. Key drivers include the rising burden of cancer and rare genetic diseases, rapid adoption of genomic profiling in reproductive health and infectious diseases, and increasing public and private investments in precision medicine and population genomics projects. Large academic reference laboratories and biopharmaceutical companies are expanding the use of NGS in translational research, clinical diagnostics, and clinical trials, creating steady demand for instruments, consumables, and informatics solutions. The development of personalized treatment options, along with advances in high-throughput sequencing chemistries, long-read technologies, and AI-enabled data analysis, is further speeding up the adoption of advanced NGS platforms and significantly boosting market growth across North America.
The sequencing segment accounted for the dominant share in 2024 of the North America NGS products market, by workflow.
By workflow, the North America NGS products market is categorized into sequencing, pre-sequencing, and data analysis. In 2024, sequencing products account for the largest revenue share, reflecting their central role as the core engine of NGS workflows across research, clinical, and applied genomics laboratories in the region. Sequencing instruments and associated consumables dominate spending because they provide high-throughput, high-accuracy read generation, which is required for applications such as oncology panels, whole-genome sequencing, and rare disease diagnostics.
The academic & research institutes segment dominated the market in 2024.
By end user, the market is divided into academic institutions, research institutes, pharmaceutical & biotechnology companies, hospitals & clinical labs, and other end users. Academic & research institutes accounted for the largest share in 2024, aided by their use of outsourced sequencing and bioinformatics services for introductory genomics, translational research, and collaborative projects. Many universities and research hospitals prefer to rely on specialized service providers for high-throughput runs, complex study designs, and advanced data analysis, rather than building all these capabilities in-house.
The US is expected to be the fastest-growing region in the North America next-generation sequencing market during the forecast period.
By country, the North America NGS market is divided into the US and Canada. The US holds a larger share and is also growing at the fastest rate. This is mainly because academic medical centers, large reference laboratories, and major biopharma companies are expanding their use of NGS in target-based panels, exome sequencing, and whole-genome sequencing. Canada is also experiencing growth. Adoption is driven by regional genomic medicine programs and collaborative research networks that are increasing access to sequencing and generating real-world clinical evidence. Overall, growth across North America is supported by a robust healthcare and research infrastructure, the broader adoption of precision oncology, and advancements in rare-disease genomics—sustained public and private funding for population-scale sequencing programs and biopharmaceutical R&D.
Key companies active in the North America NGS market include Illumina (US), Thermo Fisher Scientific (US), Roche (Switzerland), and Danaher (US), along with other regional and global companies.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the North America Next-generation Sequencing Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
